Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sjörgren's syndrome

European Journal of Clinical Nutrition

Volumn 56, Issue 11, 2002, Pages 1087-1093

  Tovar, A R ^a   Gomez E ^a   Bourges, H ^a   Ortiz V ^a   Kraus, A ^a   Torres, N ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Aspartate aminotransferase; Interleukin 2; Pyridoxine; Sj gren's syndrome; T lymphocytes; Vitamins

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ERYTHROCYTE ENZYME; INTERLEUKIN 2; MESSENGER RNA; PHYTOHEMAGGLUTININ; PLACEBO; PYRIDOXINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; PROTEIN EXPRESSION; PYRIDOXINE DEFICIENCY; SJOEGREN SYNDROME; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ASPARTATE AMINOTRANSFERASES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; PHYTOHEMAGGLUTININS; PYRIDOXINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SJOGREN'S SYNDROME; T-LYMPHOCYTES; VITAMIN B 6 DEFICIENCY;

EID: 0036859125     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601450     Document Type: Article

References (49)

1. Ahmed SA, Penhale WJ & Talal N (1985): Sex hormones, immune responses and autoimmune diseases. Am. J. Pathol. 121, 531-551.
2. Al-Janadi M, Al-Balla S, Al-Dalaan A & Raziuddin S (1993): Cytokine profile in systematic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J. Clin. Immunol. 1, 58-67.
3. Alarcón-Segovia D (1989): Primary Sjögren's syndrome: six characters in search of an author. J. Rheumatol. 16, 1177-1178.
4. Alcocer-Varela J, Laffon A & Alarcón-Segovia D (1984): Differences in the production of and/or the response to interleukin-2 by T-lymphocytes from patients with the various connective tissue diseases. Rheumatol. Int. 4, 39-44.
5. Alvarez-Celorio MA, Angeles-Angeles A & Kraus A (2000): Primary Sjögren's syndrome and celiac disease. J. Clin. Rheumatol. 6, 194-197.
6. Axelrod AE & Trakatellis AC (1964): Relationship of pyridoxine to immunological phenomena. Vitam. Horm. 22, 591-607.
7. Aziz KE, McCluskey PJ & Wakefield D (1994): Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjögren's syndrome. Cytometry 15, 35-41.
8. Beisel W (1982): Single nutrients and immunity. Am. J. Clin. Nutr. 35(Suppl), 417-468.
9. Beisel W (1990): Vitamins and the immune system. Ann. NY Acad. Sci. 587, 5-8.
10. Bhalla AK (1989): Hormones and the immune response. Ann. Rheum. Dis. 48, 1-6.
11. Boumba D, Skopouli FN & Moutsopoulos HM (1995): Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br. J. Rheumatol. 34, 326-333.
12. Boyum A (1968): Isolation of mononuclear cells and granulocytes from human blood. Scan. J. Clin. Lab. Invest. 21 (Suppl), 77-89.
13. Chandra RK (1991): Nutrition and immunity: lessons from the past and new insights into the future. Am. J. Clin. Nutr. 53, 1087-1101.
14. Chandra R, Au B & Heresi G (1981): Single nutrient deficiency and cell-mediated immune responses. II. Pyridoxine. Nutr. Res. 1, 101-106.
15. Chomczynski P (1993): A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio Techniques 15, 532-536.
16. Coligan JE, Kruisbeek AM, Margulis DH, Sheavach EM & Strober W (1992): Current Protocols in Immunology. New York: John Wiley & Sons.
17. Daniels TE & Talal N (1987): Diagnosis and differential diagnosis of Sjögren's syndrome. In Sjören's Syndrome. Clinical and Immunological Aspects, eds. N Talal, HM Moutsopoulos & SS Kassan, pp 150-165. Germany: Springer-Verlag.
18. Fox RI, Robinson C, Curd JC, Michelson P, Kozin F & Howell FV (1986): Sjögren's syndrome: proposed criteria for classification. Athritis Rheum. 29, 577-585.
19. Harbige LS (1996): Nutrition and immunity with emphasis on infection and autoimmune disease. Nutr. Health 10, 285-312.
20. Hernandez M, Chavez A & Bourges H (1977): Valor Nutritivo de los Alimentos Mexicanos. Mexico: Publication L-12 de la Division de Nutrición, Instituto Nacional de la Nutricion.
21. Horrobin D (1984): Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjögren's syndrome. Med. Hypoth. 14, 233-247.
22. Horrobin D (1986): Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systematic sclerosis and rheumatoid arthritis. Scand. J. Rheumatol. 61 (Suppl), 242-245.
23. Horrobin D & Campbell A (1980): Sjögren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C. Med. Hypoth. 6, 225-232.
24. Horrobin DF, Oka M & Manku MS (1979): The regulation of prostaglandin E1 formation: a candidate for one of the fundamental mechanisms involved in the actions of vitamin C. Med. Hypoth. 5, 849-858.
25. Horrobin D, Campbell A & McEwan CG. (1981): Treatment of the sicca syndrome and Sjögren's syndrome with EFA, pyridoxine and vitamin C. Prog. Lipid Res. 20, 253-254.
26. Karmen A (1955): A note on the spectrophotometric assay for glutamic oxaloacetic transaminase in human blood serum. J. Clin. Invest. 34, 131-133.
27. Kater L & deWilde PCM (1992): New developments in Sjögren's syndrome. Curr. Opin. Rheumatol. 4, 657-665.
28. Kraus A, Caballero-Uribe C, Jakez J, Villa A & Alarcón-Segovia D (1992): Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations. J. Rheumatol. 19, 1572-1574.
29. Kroemer G & Martínez AC (1991): Cytokines and autoimmune disease. Clin. Immunol. Immunopathol. 61, 275-295.
30. 6: a status report. J. Nutr. 120, 1503-1507.
31. Manthrope R, Oxholm P, Prause JU & Schiødt M (1986): The Copenhagen criteria for Sjögren's syndrome. Scand. J. Rheumatol. 61 (Suppl), 19-21.
32. 6 impairs interleukin 2 production and lymphocyte proliferation in elderly adults. Am. J. Clin. Nutr. 53, 1275-1280.
33. Moriuchi J, Ichikawa Y, Takaya M, Shimizu H, Tsuji K, Wakisaka A, Dawkins R & Arimori S (1991): Association of the complement allele C4AQO with primary Sjögren's syndrome in Japanese patients. Arthritis Rheum. 34, 224-227.
34. Pettersson T, Metsärinne K, Teppo AM & Fyhrquist F (1992): Immunoreactive interleukine-6 in serum of patients with B-lymphoproliferative diseases. J. Intern. Med. 232, 439-442.
35. Rall LC & Meydani SN (1993): Vitamin B6 and immune competence. Nutr. Rev. 51, 217-225.
36. Ravn P, Linnet J, Klokker M & Pedersen BK (1995): Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural killer cell activity. Immunopharmacology 30, 247-253.
37. Reveille JD (1992): The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr. Opin. Rheumatol. 4, 644-656.
38. Salvarani C, Machioni P, Lodi P, lori I, Bolardi L, Bertorelli G, Rossi F, Panciroli G & Portioli I (1991): Sjögren's syndrome in human immunodeficiency virus (HIV) infection: association with HLA-DR3 and CD8 lymphocytosis in an Italian patient. Clin. Exp. Rheumatol. 90, 286-294.
39. Shiozawa S, Shizawa K & Shimizu S (1990): Immuno reactive circulating alpha-interfon is low in Sjögren's syndrome. Br. J. Rheumatol. 29, 50-52.
40. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcón-Segovia D & Kraus A (1998): Oral candidiasis and Sjögren's Syndrome. J. Rheumatol. 25, 911-915.
41. Stanulovic M, Miletic D & Stock A (1967): The diagnosis of pyridixine deficiency based on the estimation of erythrocytic aspartate aminotransferase and its stimulation in vitro with pyridoxal-5-phosphate. Clin. Chem. Acta 17, 353-362.
42. Struyf N, Snoeck H, Bridts C, De Clerck L & Stevens J (1990): Natural killer cell activity in Sjögren's syndrome and systematic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes. Ann. Rheum. Dis. 49, 690-693.
43. Talbott M, Miller L & Kerkvliet N (1987): Pyridoxine supplementation: effect on lymphocyte responses in elderly persons. Am. J. Clin. Nutr. 46, 659-664.
44. Tovar A, Bourges H, Canto T, Torres N & López-Castro B (1985): Effect of oral contraceptive use on the erythrocyte glutathione reductase and aspartate aminotransferase activities in women with or without clinical signs of vitamin deficiency. Nutr. Rep. Int. 32, 199-209.
45. Tovar AR, Torres N, Halhali A & Bourges H (1996): Riboflavin and pyridoxine status in a group of pregnant Mexican women. Arch. Med. Res. 27, 195-200.
46. Trakatellis A, Dimitriadou A, Exindari M, Scountzou J, Koliakos G, Christododoulou D, Malissiovas N, Antoniadis A & Polyzoni T (1992): Effect of pyridoxine deficiency on immunological phenomena. Postgrad. Med. J. 68(Suppl 1), S70-S77.
47. U.S. Department of Agriculture (1985): Nutrient data base for standard reference expansion of data published in composition of foods, raw. Processed, prepared (Revision of USDA Handbook 8-1 tp 8-16). Washington, DC: U.S. Goverment Printing Office.
48. Van den Berg H, Mulder J, Spanhaak S, Dokkum WV & Ockhuizen T (1998): In The Influence of Marginal B-6 Status on Immunological Indicies, eds. JE Leklem & RD Reynold, pp 147-155. New York: A.R. Liss Inc.
49. Vitali C, Bombardieri S, Moutsopoulus HM, Balestrieri G, Bencivelli W, Bernstein RM & Bjerrum KB (1993): Preliminary criteria for the classification of Sjögren's syndrome. Arthrits Rheum. 36,